Helen Dakin
Colleges
Helen Dakin
MSc DPhil
Senior Researcher
Helen Dakin joined the Health Economics Research Centre in February 2008. Before starting at HERC, she worked at Abacus International and completed her MSc in Economic Evaluation in Healthcare at City University. She previously graduated from Cambridge University with Masters and Bachelor's degrees in Biochemistry. In 2014, she completed a DPhil at the University of Oxford on the optimal methods for conducting economic evaluations of factorial clinical trials.
Her current projects include: the STAR trial, which evaluates radiotherapy alongside bevacizumab (Avastin) in age-related macular degeneration; the ACHE study, which evaluates clinical tools and thresholds for selecting patients for joint replacement; and the KAT trial, which assesses the cost-effectiveness of different types of knee replacement component.
Research paper on factors influencing NICE decisions available here.
Recent publications
-
Partial factorial trials: comparing methods for statistical analysis and economic evaluation.
Journal article
Dakin HA. et al, (2018), Trials, 19
-
Decision Making for Healthcare Resource Allocation: Joint v. Separate Decisions on Interacting Interventions.
Journal article
Dakin H. and Gray A., (2018), Med Decis Making, 38, 476 - 486
-
Associations between preoperative Oxford hip and knee scores and costs and quality of life of patients undergoing primary total joint replacement in the NHS England: an observational study.
Journal article
Eibich P. et al, (2018), BMJ Open, 8
-
Review and critical appraisal of studies mapping from quality of life or clinical measures to EQ-5D: an online database and application of the MAPS statement.
Journal article
Dakin H. et al, (2018), Health Qual Life Outcomes, 16
-
Economic evaluation of factorial randomised controlled trials: challenges, methods and recommendations.
Journal article
Dakin H. and Gray A., (2017), Stat Med, 36, 2814 - 2830